Rossari Biotech Limited (NSE:ROSSARI)
504.00
-3.55 (-0.70%)
Jul 31, 2026, 3:29 PM IST
Rossari Biotech Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Rossari Biotech stock has a consensus rating of "Buy" and an average price target of ₹610.50. The average 1-year stock price forecast is 21.13% higher than the current stock price, while the lowest is ₹570.00 (+13.10%) and the highest is ₹637.00 (+26.39%).
Price Target: ₹610.50 (+21.13%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rossari Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Oct '25 | Jan '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
26.52B
from 23.96B
Increased by 10.67%
Revenue Next Year
29.73B
from 26.52B
Increased by 12.09%
EPS This Year
27.03
from 26.93
Increased by 0.38%
EPS Next Year
33.60
from 27.03
Increased by 24.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.